<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">465761844</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180323111901.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170327e19901201xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/BF02987103</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/BF02987103</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Induced hyperglycemia and tumor chemotherapy: Experimental and clinical studies</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[S. Osinsky, G. Evtushenko, E. Annin, L. Bubnovskaja]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">In order to clarify the influence of induced hyperglycemia upon antitumor effects of chemotherapy we studied some animal and human tumors. We observed that hyperglycemia enhances the antitumor effects of some cytostatic drugs several fold, due in part to the changes in the microphysiology induced by the hyperglycemia. Time doubling of some transplanted rat tumors and survival time of rats, rabbits and dogs bearing the transplanted and spontaneous tumors increased two to ten fold when the chemotherapy was used under hyperglycemia. Remission duration in patients with malignant brain glioma was enhanced by an average of six months; two years survival increased two-fold and the three years survival in patients with ovarian carcinoma in Stage III-IV increased two-fold; five years survival, 1.5-fold. The number of complications due to the combination of hyperglycemia and chemotherapy were not increased significantly. The problems of combination chemotherapy and hyperglycemia for oncologic patients' treatment are under discussion.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Humana Press Inc., 1990</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Hyperglycemia</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Antitumor drugs</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Tumor therapy</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Osinsky</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">R. E. Kavetsky Institute for Oncology Problems, Academy of Sciences of Ukrainian S.S.R., Vasilkovskaja Str. 45, 252022, Kiev-022, USSR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Evtushenko</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">R. E. Kavetsky Institute for Oncology Problems, Academy of Sciences of Ukrainian S.S.R., Vasilkovskaja Str. 45, 252022, Kiev-022, USSR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Annin</subfield>
   <subfield code="D">E.</subfield>
   <subfield code="u">R. E. Kavetsky Institute for Oncology Problems, Academy of Sciences of Ukrainian S.S.R., Vasilkovskaja Str. 45, 252022, Kiev-022, USSR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Bubnovskaja</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">R. E. Kavetsky Institute for Oncology Problems, Academy of Sciences of Ukrainian S.S.R., Vasilkovskaja Str. 45, 252022, Kiev-022, USSR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Medical Oncology and Tumor Pharmacotherapy</subfield>
   <subfield code="d">Humana Press</subfield>
   <subfield code="g">7/4(1990-12-01), 249-256</subfield>
   <subfield code="x">0736-0118</subfield>
   <subfield code="q">7:4&lt;249</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">7</subfield>
   <subfield code="o">12032</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/BF02987103</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/BF02987103</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Osinsky</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">R. E. Kavetsky Institute for Oncology Problems, Academy of Sciences of Ukrainian S.S.R., Vasilkovskaja Str. 45, 252022, Kiev-022, USSR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Evtushenko</subfield>
   <subfield code="D">G.</subfield>
   <subfield code="u">R. E. Kavetsky Institute for Oncology Problems, Academy of Sciences of Ukrainian S.S.R., Vasilkovskaja Str. 45, 252022, Kiev-022, USSR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Annin</subfield>
   <subfield code="D">E.</subfield>
   <subfield code="u">R. E. Kavetsky Institute for Oncology Problems, Academy of Sciences of Ukrainian S.S.R., Vasilkovskaja Str. 45, 252022, Kiev-022, USSR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Bubnovskaja</subfield>
   <subfield code="D">L.</subfield>
   <subfield code="u">R. E. Kavetsky Institute for Oncology Problems, Academy of Sciences of Ukrainian S.S.R., Vasilkovskaja Str. 45, 252022, Kiev-022, USSR</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Medical Oncology and Tumor Pharmacotherapy</subfield>
   <subfield code="d">Humana Press</subfield>
   <subfield code="g">7/4(1990-12-01), 249-256</subfield>
   <subfield code="x">0736-0118</subfield>
   <subfield code="q">7:4&lt;249</subfield>
   <subfield code="1">1990</subfield>
   <subfield code="2">7</subfield>
   <subfield code="o">12032</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
